# Jazz Pharmaceuticals (JAZZ): value investors who own it

2 value investors held Jazz Pharmaceuticals in their Q3 2026 13F, led by Tweedy, Browne, Polen Capital Management.

## 13F holders

| Manager | Portfolio | Value | Change | Quarters held |
| --- | --- | --- | --- | --- |
| Tweedy, Browne | 1.1% | $14.5m | Trimmed -0.1% | 2 |
| Polen Capital Management | 0.0% | $448k | New | 1 |

## Directors buying and selling (Form 4, last 12 months)

| Date | Who | Role | Bought or sold | Shares | Value |
| --- | --- | --- | --- | --- | --- |
| 2026-10-06 | GALA RENEE D | President & CEO | Sold | 2000 | $473k |
| 2026-10-01 | COZADD BRUCE C | Director | Sold | 6000 | $1.4m |
| 2026-09-10 | Patil Neena M | EVP & Chief Legal Officer | Sold | 1200 | $289k |
| 2026-09-08 | GALA RENEE D | President & CEO | Sold | 2000 | $486k |
| 2026-09-01 | COZADD BRUCE C | Director | Sold | 6000 | $1.5m |
| 2026-08-27 | Iannone Robert | EVP, Global Head of R&D & CMO | Sold | 19639 | $4.9m |
| 2026-08-27 | Iannone Robert | EVP, Global Head of R&D & CMO | Sold | 18113 | $4.5m |
| 2026-08-27 | Iannone Robert | EVP, Global Head of R&D & CMO | Sold | 18187 | $4.5m |
| 2026-08-27 | Iannone Robert | EVP, Global Head of R&D & CMO | Sold | 11423 | $2.8m |
| 2026-08-27 | Iannone Robert | EVP, Global Head of R&D & CMO | Sold | 9259 | $2.3m |
| 2026-08-27 | Iannone Robert | EVP, Global Head of R&D & CMO | Sold | 300 | $76k |
| 2026-08-03 | COZADD BRUCE C | Director | Sold | 6000 | $1.5m |

Source: SEC filings, via moatshark (https://www.moatshark.com/s/jazz). Values traded and returns are estimates. Not investment advice. Built 2026-10-21.